Brawn Biotech Ltd
Brawn Biotech Ltd (BRAWN) last traded at ₹23.1, a market capitalisation of ₹6.92 crore, on a P/E of 53.2. Over the past 52 weeks the stock has ranged between ₹17.7 and ₹24.4. Brawn Biotech Ltd last reported results for the quarter ended Jun 2023, with sales of ₹0.12 crore and net profit of ₹-0.04 crore. Brawn Biotech Ltd’s annual general meeting is scheduled for 29 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Brawn Biotech Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Brawn Biotech Ltd quarterly results
| ₹ crore | Jun 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|
| Sales | 0.12 | 0.12 | 0.12 |
| Expenses | 0.09 | 0.08 | 0.16 |
| Operating profit | 0.03 | 0.04 | -0.04 |
| OPM % | 25.00% | 33.33% | -33.33% |
| Other income | 0 | 0.23 | 0 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 0.03 | 0.27 | -0.04 |
| Tax % | 0.00% | 14.81% | 0.00% |
| Net profit | 0.02 | 0.23 | -0.04 |
| EPS (₹) | 0.07 | 0.77 | -0.13 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Brawn Biotech Ltd annual results
| ₹ crore | Mar 2023 |
|---|---|
| Sales | 0.48 |
| Operating profit | -0.01 |
| OPM % | -2.08% |
| Net profit | 0.19 |
| EPS (₹) | 0.63 |
TTM is the trailing twelve months to the most recent quarter.
Brawn Biotech Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- -5%
- 5 Years
- 2%
- 3 Years
- 3%
- 1 Year
- 11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Brawn Biotech Ltd shareholding pattern
Promoters held 52.94% at Jun 2026, down from 53.66% at Jun 2025. DIIs 0.35%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 53.64% | 53.64% | 53.66% | 53.66% | 53.66% | 53.39% | 52.94% | 52.94% |
| DIIs | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% |
| Public | 46.02% | 46.02% | 46.01% | 46.00% | 45.99% | 46.27% | 46.72% | 46.72% |
| No. of shareholders | 4,157 | 4,060 | 4,024 | 3,975 | 3,958 | 3,444 | 3,303 | 3,284 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Brawn Biotech Ltd’s AGM?
Brawn Biotech Ltd’s annual general meeting is scheduled for 29 Sept 2026.
- AGMConvening of the 41st Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Brawn Biotech Ltd corporate filings
- Publication of Un-audited financial results for the quarter ended June 30, 2026.Company Updatehigh impact
Cruxal's analysis: Brawn Biotech Ltd. reported its unaudited financial results for the quarter ended 30 June…
Read the full analysis - Outcome of Board Meeting held on August 13, 2026 to consider and approve, inter-alia, un-audited financial results of the company for quarter ended June 30, 2026.Board Meetingmedium impact
Cruxal's analysis: Brawn Biotech Limited reported revenue from operations of 6.08 crore for the quarter…
Read the full analysis - Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....Board Meetinglow impact
Cruxal's analysis: Brawn Biotech Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Brawn Biotech Ltd
Cruxal reads every Brawn Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.